Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Rivaroxaban Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
2.5mg/Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Rivaroxaban Tablets include Bayer, Janssen Pharmaceuticals, Beijing SL Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Fujian Cosunter Pharmaceutical, Lunan Pharmaceutical, Shanghai Huilun Pharmaceutical, Jilin Boda Pharmaceutical and Cspc Holdings Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Rivaroxaban tablets are anticoagulants (blood thinners) used to treat and prevent blood clots. Specifically, it is used to treat deep vein thrombosis and pulmonary embolism, and to prevent atrial fibrillation and blood clots after hip or knee surgery. It is taken orally. Common side effects include bleeding. Other serious side effects may include spinal epidural hematoma and anaphylactic shock. It is not known if it is safe to use during pregnancy and breastfeeding. It has fewer interactions with other drugs than warfarin. It works by blocking the activity of the clotting protein coagulation factor Xa.
This report aims to provide a comprehensive presentation of the global market for Rivaroxaban Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rivaroxaban Tablets. This report contains market size and forecasts of Rivaroxaban Tablets in global, including the following market information:
Global Rivaroxaban Tablets Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rivaroxaban Tablets Market Sales, 2018-2023, 2024-2029, (K Boxes)
Global top five Rivaroxaban Tablets companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rivaroxaban Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rivaroxaban Tablets Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Boxes)
Global Rivaroxaban Tablets Market Segment Percentages, by Type, 2022 (%)
2.5mg/Tablet
10mg/Tablet
15mg/Tablet
20mg/Tablet
Global Rivaroxaban Tablets Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Boxes)
Global Rivaroxaban Tablets Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Drugstore
Global Rivaroxaban Tablets Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Boxes)
Global Rivaroxaban Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rivaroxaban Tablets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rivaroxaban Tablets revenues share in global market, 2022 (%)
Key companies Rivaroxaban Tablets sales in global market, 2018-2023 (Estimated), (K Boxes)
Key companies Rivaroxaban Tablets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Janssen Pharmaceuticals
Beijing SL Pharmaceutical
Nanjing Zhengda Tianqing Pharmaceutical
Fujian Cosunter Pharmaceutical
Lunan Pharmaceutical
Shanghai Huilun Pharmaceutical
Jilin Boda Pharmaceutical
Cspc Holdings Company
Zhejiang Conba Pharmaceutical
Suzhou No.3 Pharmaceutical
Chengdu Baiyu Pharmaceuticals
Jiangsu Zhongbang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rivaroxaban Tablets, market overview.
Chapter 2: Global Rivaroxaban Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Rivaroxaban Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rivaroxaban Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rivaroxaban Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Rivaroxaban Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rivaroxaban Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rivaroxaban Tablets Overall Market Size
2.1 Global Rivaroxaban Tablets Market Size: 2022 VS 2029
2.2 Global Rivaroxaban Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Rivaroxaban Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Rivaroxaban Tablets Players in Global Market
3.2 Top Global Rivaroxaban Tablets Companies Ranked by Revenue
3.3 Global Rivaroxaban Tablets Revenue by Companies
3.4 Global Rivaroxaban Tablets Sales by Companies
3.5 Global Rivaroxaban Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Rivaroxaban Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Rivaroxaban Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rivaroxaban Tablets Players in Global Market
3.8.1 List of Global Tier 1 Rivaroxaban Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Rivaroxaban Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Rivaroxaban Tablets Market Size Markets, 2022 & 2029
4.1.2 2.5mg/Tablet
4.1.3 10mg/Tablet
4.1.4 15mg/Tablet
4.1.5 20mg/Tablet
4.2 By Type - Global Rivaroxaban Tablets Revenue & Forecasts
4.2.1 By Type - Global Rivaroxaban Tablets Revenue, 2018-2023
4.2.2 By Type - Global Rivaroxaban Tablets Revenue, 2024-2029
4.2.3 By Type - Global Rivaroxaban Tablets Revenue Market Share, 2018-2029
4.3 By Type - Global Rivaroxaban Tablets Sales & Forecasts
4.3.1 By Type - Global Rivaroxaban Tablets Sales, 2018-2023
4.3.2 By Type - Global Rivaroxaban Tablets Sales, 2024-2029
4.3.3 By Type - Global Rivaroxaban Tablets Sales Market Share, 2018-2029
4.4 By Type - Global Rivaroxaban Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rivaroxaban Tablets Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Drugstore
5.2 By Application - Global Rivaroxaban Tablets Revenue & Forecasts
5.2.1 By Application - Global Rivaroxaban Tablets Revenue, 2018-2023
5.2.2 By Application - Global Rivaroxaban Tablets Revenue, 2024-2029
5.2.3 By Application - Global Rivaroxaban Tablets Revenue Market Share, 2018-2029
5.3 By Application - Global Rivaroxaban Tablets Sales & Forecasts
5.3.1 By Application - Global Rivaroxaban Tablets Sales, 2018-2023
5.3.2 By Application - Global Rivaroxaban Tablets Sales, 2024-2029
5.3.3 By Application - Global Rivaroxaban Tablets Sales Market Share, 2018-2029
5.4 By Application - Global Rivaroxaban Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Rivaroxaban Tablets Market Size, 2022 & 2029
6.2 By Region - Global Rivaroxaban Tablets Revenue & Forecasts
6.2.1 By Region - Global Rivaroxaban Tablets Revenue, 2018-2023
6.2.2 By Region - Global Rivaroxaban Tablets Revenue, 2024-2029
6.2.3 By Region - Global Rivaroxaban Tablets Revenue Market Share, 2018-2029
6.3 By Region - Global Rivaroxaban Tablets Sales & Forecasts
6.3.1 By Region - Global Rivaroxaban Tablets Sales, 2018-2023
6.3.2 By Region - Global Rivaroxaban Tablets Sales, 2024-2029
6.3.3 By Region - Global Rivaroxaban Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Rivaroxaban Tablets Revenue, 2018-2029
6.4.2 By Country - North America Rivaroxaban Tablets Sales, 2018-2029
6.4.3 US Rivaroxaban Tablets Market Size, 2018-2029
6.4.4 Canada Rivaroxaban Tablets Market Size, 2018-2029
6.4.5 Mexico Rivaroxaban Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Rivaroxaban Tablets Revenue, 2018-2029
6.5.2 By Country - Europe Rivaroxaban Tablets Sales, 2018-2029
6.5.3 Germany Rivaroxaban Tablets Market Size, 2018-2029
6.5.4 France Rivaroxaban Tablets Market Size, 2018-2029
6.5.5 U.K. Rivaroxaban Tablets Market Size, 2018-2029
6.5.6 Italy Rivaroxaban Tablets Market Size, 2018-2029
6.5.7 Russia Rivaroxaban Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Rivaroxaban Tablets Market Size, 2018-2029
6.5.9 Benelux Rivaroxaban Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Rivaroxaban Tablets Revenue, 2018-2029
6.6.2 By Region - Asia Rivaroxaban Tablets Sales, 2018-2029
6.6.3 China Rivaroxaban Tablets Market Size, 2018-2029
6.6.4 Japan Rivaroxaban Tablets Market Size, 2018-2029
6.6.5 South Korea Rivaroxaban Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Rivaroxaban Tablets Market Size, 2018-2029
6.6.7 India Rivaroxaban Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Rivaroxaban Tablets Revenue, 2018-2029
6.7.2 By Country - South America Rivaroxaban Tablets Sales, 2018-2029
6.7.3 Brazil Rivaroxaban Tablets Market Size, 2018-2029
6.7.4 Argentina Rivaroxaban Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rivaroxaban Tablets Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Rivaroxaban Tablets Sales, 2018-2029
6.8.3 Turkey Rivaroxaban Tablets Market Size, 2018-2029
6.8.4 Israel Rivaroxaban Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Rivaroxaban Tablets Market Size, 2018-2029
6.8.6 UAE Rivaroxaban Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Rivaroxaban Tablets Major Product Offerings
7.1.4 Bayer Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Janssen Pharmaceuticals
7.2.1 Janssen Pharmaceuticals Company Summary
7.2.2 Janssen Pharmaceuticals Business Overview
7.2.3 Janssen Pharmaceuticals Rivaroxaban Tablets Major Product Offerings
7.2.4 Janssen Pharmaceuticals Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Janssen Pharmaceuticals Key News & Latest Developments
7.3 Beijing SL Pharmaceutical
7.3.1 Beijing SL Pharmaceutical Company Summary
7.3.2 Beijing SL Pharmaceutical Business Overview
7.3.3 Beijing SL Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.3.4 Beijing SL Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Beijing SL Pharmaceutical Key News & Latest Developments
7.4 Nanjing Zhengda Tianqing Pharmaceutical
7.4.1 Nanjing Zhengda Tianqing Pharmaceutical Company Summary
7.4.2 Nanjing Zhengda Tianqing Pharmaceutical Business Overview
7.4.3 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.4.4 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.4.5 Nanjing Zhengda Tianqing Pharmaceutical Key News & Latest Developments
7.5 Fujian Cosunter Pharmaceutical
7.5.1 Fujian Cosunter Pharmaceutical Company Summary
7.5.2 Fujian Cosunter Pharmaceutical Business Overview
7.5.3 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.5.4 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Fujian Cosunter Pharmaceutical Key News & Latest Developments
7.6 Lunan Pharmaceutical
7.6.1 Lunan Pharmaceutical Company Summary
7.6.2 Lunan Pharmaceutical Business Overview
7.6.3 Lunan Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.6.4 Lunan Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.6.5 Lunan Pharmaceutical Key News & Latest Developments
7.7 Shanghai Huilun Pharmaceutical
7.7.1 Shanghai Huilun Pharmaceutical Company Summary
7.7.2 Shanghai Huilun Pharmaceutical Business Overview
7.7.3 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.7.4 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.7.5 Shanghai Huilun Pharmaceutical Key News & Latest Developments
7.8 Jilin Boda Pharmaceutical
7.8.1 Jilin Boda Pharmaceutical Company Summary
7.8.2 Jilin Boda Pharmaceutical Business Overview
7.8.3 Jilin Boda Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.8.4 Jilin Boda Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.8.5 Jilin Boda Pharmaceutical Key News & Latest Developments
7.9 Cspc Holdings Company
7.9.1 Cspc Holdings Company Company Summary
7.9.2 Cspc Holdings Company Business Overview
7.9.3 Cspc Holdings Company Rivaroxaban Tablets Major Product Offerings
7.9.4 Cspc Holdings Company Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.9.5 Cspc Holdings Company Key News & Latest Developments
7.10 Zhejiang Conba Pharmaceutical
7.10.1 Zhejiang Conba Pharmaceutical Company Summary
7.10.2 Zhejiang Conba Pharmaceutical Business Overview
7.10.3 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.10.4 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.10.5 Zhejiang Conba Pharmaceutical Key News & Latest Developments
7.11 Suzhou No.3 Pharmaceutical
7.11.1 Suzhou No.3 Pharmaceutical Company Summary
7.11.2 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Business Overview
7.11.3 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.11.4 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.11.5 Suzhou No.3 Pharmaceutical Key News & Latest Developments
7.12 Chengdu Baiyu Pharmaceuticals
7.12.1 Chengdu Baiyu Pharmaceuticals Company Summary
7.12.2 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Business Overview
7.12.3 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Major Product Offerings
7.12.4 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.12.5 Chengdu Baiyu Pharmaceuticals Key News & Latest Developments
7.13 Jiangsu Zhongbang Pharmaceutical
7.13.1 Jiangsu Zhongbang Pharmaceutical Company Summary
7.13.2 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Business Overview
7.13.3 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Major Product Offerings
7.13.4 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Sales and Revenue in Global (2018-2023)
7.13.5 Jiangsu Zhongbang Pharmaceutical Key News & Latest Developments
8 Global Rivaroxaban Tablets Production Capacity, Analysis
8.1 Global Rivaroxaban Tablets Production Capacity, 2018-2029
8.2 Rivaroxaban Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Rivaroxaban Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rivaroxaban Tablets Supply Chain Analysis
10.1 Rivaroxaban Tablets Industry Value Chain
10.2 Rivaroxaban Tablets Upstream Market
10.3 Rivaroxaban Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rivaroxaban Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
